We have developed the first approach to making T-Cell Priming Vaccines using experimentally selected purely synthetic non-biological components that program immune cells to destroy pathogen producing cells.

These vaccines modify the initial immune status of the recipients in a way that ‘primes’ their immune systems to recognise subsequent infectious agents much like a natural infection would do, and thus preventing an acute or severe manifestation of the disease.